Join The AFTD-Team! Click here to get involved.



AFTD’s Partners in FTD Care


AFTD Kids and Teens





TauRx Logo Big copy

LMTX®, a new drug from TauRx: Designed to undo tau tangles in the brain, has concluded phase 3 clinical trial in patients with mild to moderate Alzheimer’s disease. Results were disappointingly negative (the patients taking the drug were no different from those not taking the drug after 15 months). However, a small subgroup (15%) of patients not on standard Alzheimer’s medications may have seen some benefit; analysis of the results, which will be published later this year, continues. Read the New York Times coverage here or BBC coverage here. FTD trials on LMTX® will be reported at the International Conference on Frontotemporal Dementias in Munich – August 31-September 2, 2016.
AFTD Team Logo (Walk Run 2016) AFTD-Team: Griffith Luau, Los Angeles, CA – Join the AFTD-Team for the Griffith Luau on Saturday, August 13th. Participants have their choice of running/walking in the 5K, or Kids 1K on Saturday. Grassroots events like these are a great way to get information out about FTD and meet others in your local area. Your support helps to raise funds toward AFTD’s mission while supporting our community. Register today!
Celia Huey AFTD’s Kids and Teens Site: When asked how she felt when learning more about FTD, Celia Huey, age 11, explained “Before I knew much about the brain, I thought dementia meant that you don’t have a good memory. I couldn’t imagine that something as important as your personality and behaviors could be taken away by dementia.” Our Kids & Teens site offers vital peer perspectives that will be of value to young members of families impacted by FTD. Encourage them to visit the site and share their experiences today: